1

NMD Listening Session Agenda - 4

DOR Natural Medicine Division Listening Session #4:

Laboratory Testing Program

September 27, 2023 │ 10:00 a.m. - 11:00 a.m.

 

Join Zoom Meeting Here

Meeting ID: 854 0245 2433

 

Agenda:

  1. Overview of Statutory Requirements

  2. Presentation from State Experts

    • Overview of Colorado’s cannabis testing program

    • Overview of Oregon’s psilocybin testing program

  3. Preview of target audiences and of education focus areas

  4. Open Discussion

 

Discussion Questions:

The following questions are intended to guide initial discussions to assist attendees as they prepare for the Listening Session. Attendees are invited to raise additional questions or topics that are not contemplated in this list but relevant to the Listening Session topic.

  • What testing categories are most critical for natural medicine? (e.g. heavy metals / elemental impurities, pesticides, microbial contaminants)

    • What testing categories are specific to certain types of natural medicine? (e.g.psilocybe mushrooms)

  • How frequently should the rules require licensees to conduct testing?

  • At what points should testing occur? (e.g. prior to any transfer to a Facilitator or Healing Center, or on all final products)

  • Who should be responsible for submitting samples for testing? (e.g. the facilitator, cultivation, manufacturer, healing center)

  • Should DOR-licensed regulated marijuana testing facilities be permitted to test Natural Medicine?**
    **Note: this would require a statutory change.

 

Additional DOR-Provided Resources:

 

Additional Shared Information:
The resources below were compiled as a result of Natural Medicine Division research and outreach efforts and may not be encompassing of the world of information available, and the Division continues to invite interested parties that have relevant insight, perspectives, or information to share that with Division by emailing Allison Robinette at allison.robinette@state.co.us.

The information below is being shared for purposes of informing the Listening Session discussion and is not an endorsement of any of the organizations or the accuracy of the information.